379 related articles for article (PubMed ID: 20662754)
1. Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
Mochcovitch MD; Nardi AE
Expert Rev Neurother; 2010 Aug; 10(8):1285-93. PubMed ID: 20662754
[TBL] [Abstract][Full Text] [Related]
2. The role of SSRIs in panic disorder.
Sheehan DV; Harnett-Sheehan K
J Clin Psychiatry; 1996; 57 Suppl 10():51-8; discussion 59-60. PubMed ID: 8917132
[TBL] [Abstract][Full Text] [Related]
3. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M
Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia.
Bakker A; van Balkom AJ; van Dyck R
Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S25-30. PubMed ID: 11110016
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
7. Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.
Papakostas GI; Charles D; Fava M
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):300-7. PubMed ID: 20218793
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
Walitt B; Urrútia G; Nishishinya MB; Cantrell SE; Häuser W
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011735. PubMed ID: 26046493
[TBL] [Abstract][Full Text] [Related]
9. Different effects of selective serotonin reuptake inhibitors on a patient suffering from panic disorder.
Masuda Y; Shimizu T
Hum Psychopharmacol; 2004 Jan; 19(1):65. PubMed ID: 14716716
[No Abstract] [Full Text] [Related]
10. The use of newer antidepressants for panic disorder.
Gorman JM
J Clin Psychiatry; 1997; 58 Suppl 14():54-8; discussion 59. PubMed ID: 9418747
[TBL] [Abstract][Full Text] [Related]
11. Current concepts in the treatment of panic disorder.
Sheehan DV
J Clin Psychiatry; 1999; 60 Suppl 18():16-21. PubMed ID: 10487251
[TBL] [Abstract][Full Text] [Related]
12. Serotonin agents in the treatment of acquired brain injury.
Zafonte RD; Cullen N; Lexell J
J Head Trauma Rehabil; 2002 Aug; 17(4):322-34. PubMed ID: 12106001
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
Nemeroff CB; Entsuah R; Benattia I; Demitrack M; Sloan DM; Thase ME
Biol Psychiatry; 2008 Feb; 63(4):424-34. PubMed ID: 17888885
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological approaches to the management of panic disorder in older patients: a systematic review.
Caldirola D; De Donatis D; Alciati A; Daccò S; Perna G
Expert Rev Neurother; 2023; 23(11):1013-1029. PubMed ID: 37676054
[TBL] [Abstract][Full Text] [Related]
15. Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels.
Herrán A; Ramírez ML; Carrera M; García-Unzueta MT; Sierra-Biddle D; Rodríguez-Cabo B; Ayestarán A; Hoyuela F; Vázquez-Barquero JL
J Clin Psychopharmacol; 2006 Oct; 26(5):538-40. PubMed ID: 16974205
[No Abstract] [Full Text] [Related]
16. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
17. [Selective serotonin reuptake inhibitors--current knowledge].
Dudek D; Zieba A; Siwek M; Wróbel A
Psychiatr Pol; 2004; 38(3):507-24. PubMed ID: 15199659
[TBL] [Abstract][Full Text] [Related]
18. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Hayasaka Y; Purgato M; Magni LR; Ogawa Y; Takeshima N; Cipriani A; Barbui C; Leucht S; Furukawa TA
J Affect Disord; 2015 Jul; 180():179-84. PubMed ID: 25911132
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study.
Bertani A; Perna G; Arancio C; Caldirola D; Bellodi L
J Clin Psychopharmacol; 1997 Apr; 17(2):97-101. PubMed ID: 10950471
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of Chinese randomized clinical trials of SSRI treatment of depression.
Zhang Y; Becker T; Ma Y; Koesters M
BMC Psychiatry; 2014 Aug; 14():245. PubMed ID: 25159460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
